Precision Medicine and Novel Technology

<span style="&quot;color:" rgb(51,="" 51,="" 51);="" font-family:="" "roboto="" slab",="" serif;="" font-size:="" 13px;="" background-color:="" rgb(255,="" 255,="" 255);"="">Precision medicine aims to provide the right treatment for the right patient at the right time with treatment directed on the basis of the targetable tumoral aberrations rather than just a traditional histologic subtype. However to facilitate this approach, clinicians require patient derived samples. Prostate cancer is challenging to culture in vitro. Recent development of novel organoid in vitro culture technology has led to the development of multiple new in vitro prostate cancer cell line models. We aim to apply organoid culture technology to develop novel in vitro prostate cancer cell line models and propagate patient derived samples to allow drug testing and next generation sequencing as part of a precision medicine approach to early recurrent prostate cancer.

    Related Conference of Precision Medicine and Novel Technology

    December 01-02, 2020

    World Congress on Medical Toxicology

    Tokyo, Japan
    December 18-18, 2020

    3rd Annual Conference on Epidemiology and Public Health

    Singapore City, Singapore
    March 16-17, 2021

    4th International Conference on Ear Nose and Throat

    Sydney, Australia
    March 22-23, 2021

    7th World Congress on Anesthesia and Critical Care

    Paris, France
    March 23-24, 2021

    2nd Annual Congress on Medicine

    Tokai, Japan
    April 19-20, 2021

    8th Asian Herbal and Traditional Medicine summit

    Tokyo, Japan

    Precision Medicine and Novel Technology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in